✦ LIBER ✦

Rad51 in Regulating the Radiosensitivity of NSCLC With Different EGFR Status

✍ Scribed by Wang, J.; Zhong, X.; Luo, G.; Zhou, X.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Inhibition of the EGFR with nanoparticle

✍ Yehui ping; Zou Jian; Zhang Yi; Zhao Huoyu; Liu Feng; Yang Yuqiong; Liu Shixi 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 489 KB

Management of Nonhematologic Toxicities

✍ Passaro, Antonio; Di Maio, Massimo; Del Signore, Ester; Gori, Bruno; de Marinis, 📂 Article 📅 2014 🏛 CIG Media Group, LP. 🌐 English ⚖ 106 KB

Gefitinib effective for patients with NS

📂 Article 📅 2006 🏛 Adis International Limited (now part of Wolters Kl ⚖ 151 KB

Assessment of Patient Population with NS

✍ Schmidt, U.; Drechsler, M.; Assmann, G.; Kempel, A. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

9167 Outcomes with erlotinib in advanced

✍ Soulières, D.; Ciuleanu, T.; Stelmakh, L.; Whittom, R.; Delmar, P.; Rohr, K.; Br 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 48 KB

EGFR Inhibitors in Cancer Treatment || C

✍ Ciardiello, Fortunato 📂 Article 📅 2012 🏛 Future Medicine Ltd ⚖ 776 KB